Direct Rx is recalling 891 bottles of Duloxetine D/R (delayed-release) capsules in 20 mg and 30 mg strengths. This recall was issued because the medication was found to contain a nitrosamine impurity at levels higher than the acceptable interim limit. The recalled products include various bottle sizes distributed across the United States.
Nitrosamines are impurities that may increase the risk of cancer if individuals are exposed to them at high levels over a long period of time. No injuries or adverse events have been reported to date.
You have 2 options:
Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc.
Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.